logo
  

Takeda Presents Promising Initial Results From INSPIRE Study Of Alofisel

Takeda Pharmaceutical Co. Ltd. (TAK), said on Friday that clinical remission was observed in 65% of patients with Crohn's disease and complex perianal fistulas in a phase III trial, dubbed INSPIRE, an observational post-marketing study of Alofisel.

Alofisel, a suspension of expanded allogeneic or donor-derived, adipose-derived mesenchymal stem cells (eASC), is approved in the European Union/European Economic Area, Israel, Switzerland, the United Kingdom, and Japan.

The six-month interim analysis results from INSPIRE study are consistent with the pivotal Phase 3 ADMIRE-CD study in terms of efficacy and safety of the drug, the Tokyo-headquartered firm said.

ADMIRE-CD was a randomized, double-blind, controlled, Phase 3 trial investigating the efficacy and safety of Alofisel for the treatment of complex perianal fistulas in patients with non-active/mildly active luminal Crohn's disease.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Communications Commission or FCC has granted SpaceX Services, Inc. authorization to use its Starlink satellite internet system on vehicles in motion. SpaceX, owned by Elon Musk, is allowed to operate consumer and enterprise Ku-band Earth Stations in Motion or ESIM using frequencies allocated to the fixed satellite service. The approval would help the company to expand its services to Loud Muscle Science, LLC is recalling certain Launch Sequence products in the United States and Canada citing the presence of undeclared Tadalafil, the U.S. Food and Drug Administration said. These tainted Launch Sequence Capsule products are marketed as dietary supplements for male sexual enhancement. The U.S. Food and Drug Administration announced the intended availability of around 17 million bottles equivalent of general infant formula to be imported from New Zealand and Ireland. Under the FDA's enforcement discretion to source more infant formula to the U.S., French food company Danone SA will send 555,000 cans Aptamil Gold Plus from New Zealand.
Follow RTT